Security key
090655606
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)
CUSIP: 090655606
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 330,604
- Total 13F value
- $974,116
- Share change
- -13,998
- SEC-reported price per share
- $2.95
- Number of holders
- 11
- Value change
- -$41,559
- Number of buys
- 6
- Number of sells
- 3
- Shares outstanding
- 27,267,374
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
11
Top holders
10
BRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
BioRestorative Therapies, Inc. SEC filings
BioRestorative Therapies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 090655606
Recent filing periods:
Ownership snapshot
Top reported holders of BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
10/11
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 0.5%
1 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 0.5%.
10 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
0.5%
Ayrton Capital LLC
0.29%
BOOTHBAY FUND MANAGEMENT, LLC
0.15%
WEALTH ALLIANCE, LLC
0.15%
Cambridge Investment Research Adv...
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
0.5%
|
$706,000
135,046 shares
|
— | 31 Mar 2022 |
| Ayrton Capital LLC |
13F
Company
|
0.29%
|
$407,000
77,762 shares
|
— | 31 Mar 2022 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
0.15%
|
$209,000
40,000 shares
|
— | 31 Mar 2022 |
| WEALTH ALLIANCE, LLC |
13F
Company
|
0.15%
|
$209,000
40,000 shares
|
— | 31 Mar 2022 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
0.08%
|
$120,000
23,001 shares
|
— | 31 Mar 2022 |
| StoneX Group Inc. |
13F
Company
|
0.05%
|
$78,209
14,954 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
330,604
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
9
Q2 2022 holders
11
Holder diff
2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend